SF3B1 and myelodysplastic syndrome: While mutational landscapes in tumor or MDS samples may complicate the interpretation of the impact of SF3B1 mutation on tumorigenesis, our hESC model could be useful to uncover the mechanisms underlying gene dysregulation in splicing factor-mutant cancers.